Bisacodyl (Dulcolax) ATI PDF

Preview

Summary

ATI ALT Template...

Description

ACTIVE LEARNING TEMPLATE:

Medication

Kim STUDENT NAME Angela _____________________________________ (Dulcolax) MEDICATION bisacodyl __________________________________________________________________________

REVIEW MODULE CHAPTER ___________

CATEGORY CLASS Laxative ______________________________________________________________________

PURPOSE OF MEDICATION

Expected Pharmacological Action Stimulating enteric nerves to cause peristalsis.

Therapeutic Use Constipation

Complications Nausea, vomiting, diarrhea, tetany, alkalosis, a sensation of burning of the rectal mucosa and mild proctitis.

Medication Administration Orally: 5 to 15 mg Rectally: 10 mg as a single dose

Contraindications/Precautions Hypersensitivity to drug, intestinal obstruction, gastroenteritis, appendicitis Use cautiously in: hypersensitivity to tannic acid severe cardiovascular disease, anal or rectal fissures, pregnant or breastfeeding patients.

Interactions

Nursing Interventions Don't give tablets within 1 hour of dairy products or antacids. Assess stools for frequency and consistency. Monitor patient for electrolyte imbalances and dehydration.

Antacids and dairy products can cause gastric irritation, dyspepsia

Client Education Evaluation of Medication Effectiveness A soft, formed bowel movements, usually within 6-24 hr.

ACTIVE LEARNING TEMPLATES

Instruct patient to swallow enteric-coated tablets whole no sooner than 1 hour before or after ingesting antacids or dairy products. Advise patients that laxatives should be used only for short-term therapy. Suggest other ways to prevent constipation, such as by eating more fruits, vegetables, and whole grains to increase dietary bulk and by drinking 8 to 10 glasses of water daily.

THERAPEUTIC PROCEDURE

A7...